- 专利标题: ANTIBODIES SPECIFIC FOR CD3 AND USES THEREOF
-
申请号: US16417859申请日: 2019-05-21
-
公开(公告)号: US20190382486A1公开(公告)日: 2019-12-19
- 发明人: James Reasoner Apgar , Fang Jin , Madan Katragadda , Divya Mathur , Lioudmila Gennadievna Tchistiakova
- 申请人: Pfizer Inc.
- 申请人地址: US NY New York
- 专利权人: Pfizer Inc.
- 当前专利权人: Pfizer Inc.
- 当前专利权人地址: US NY New York
- 主分类号: C07K16/28
- IPC分类号: C07K16/28 ; C07K16/46 ; C07K16/30 ; C07K16/40 ; A61P35/00
摘要:
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
公开/授权文献
- US11434292B2 Antibodies specific for CD3 and uses thereof 公开/授权日:2022-09-06